“…Telehealth approaches mediated through noninvasive real‐time monitoring techniques enable clinicians to continuously collect progress outcomes from patients with CVD. Biosensors, an analytical device used to detect a chemical substance, can obtain vital data directly from patients' cardiac devices and transfer them to a secure server, facilitating early detection and monitoring of abnormal heart events (Piccini et al, 2016; Rosman et al, 2018). Telehealth including mHealth allows for long‐distance correspondence between patients and clinicians, education, treatment, and remote admissions (Cunningham et al, 2023).…”